How to Navigate Ecosystem Connect NEW Distinguished Investigators 
Global Conferences RLT Education RLT Components Sponsors Trial Stats
Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Contact XCancer
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comClinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy
Description:
The purpose of this study is to evaluate the retention in tumour and distribution behavior of [Lu-177]-Catalase after intratumoral injection,and preliminary evaluation the efficacy and safety of [Lu-177]-Catalase.
Sponsor:
Peking University Cancer Hospital & Institute
Contacts:
Zhi Yang, PhDpekyz@163.com
01088196196
Xiaoyi GUO, PhD2216392114@bjmu.edu.cn
01088196495
Government Study Link:
NCT05985278 - Click here to see study onClinicalTrials.gov
Share your feedback
Help us improve your experience